A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma

DSpace Repository

A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma

Author: Pak, Ekaterina; MacKenzie, Ethan L.; Zhao, Xuesong; Pazyra-Murphy, Maria F.; Park, Paul M. C.; Wu, Lei; Shaw, Daniel L.; Addleson, Emily C.; Cayer, Suzanne S.; Lopez, Begona G-C; Agar, Nathalie Y. R.; Rubin, Lee L.; Qi, Jun; Merk, Daniel J.; Segal, Rosalind A.
Tübinger Autor(en):
Merk, Daniel J.
Published in: Neuro - Oncology (2019), Bd. 21, H. 9, S. 1150-1163
Verlagsangabe: Oxford Univ Press Inc
Language: English
Full text: http://dx.doi.org/10.1093/neuonc/noz089
ISSN: 1523-5866
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)